Literature DB >> 32504648

Current insights in the pathogenesis of scleritis.

D P C Vergouwen1, A Rothova2, J C Ten Berge2, R M Verdijk3, J A M van Laar4, J R Vingerling2, M W J Schreurs5.   

Abstract

Scleritis is a sight-threatening inflammation characterized by severe pain and redness of the eye. It can cause blindness by severe complications like scleral and corneal necrosis, keratitis, and uveitis. The pathogenesis of scleritis is largely unknown due to a combination of the rarity of the disease, the little available human tissue-based research material, and the lack of animal models. The immune system is assumed to play a crucial role in the pathogenesis of scleritis. Multiple clues indicate probable antigenic stimuli in scleritis, and the involvement of matrix metalloproteinases in the destruction of scleral tissue. In this article we review the current insights into the pathogenesis of scleritis, and we suggest new hypotheses by implementing knowledge of systemic autoimmune disease pathogenesis. Understanding the pathogenesis of scleritis is crucial to improve the clinical management, as well as to find novel treatment modalities.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Imaging; Immunology; Matrix metalloproteinases; Pathology; Scleritis

Year:  2020        PMID: 32504648     DOI: 10.1016/j.exer.2020.108078

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  8 in total

1.  Comparison of Intestinal Microbes in Noninfectious Anterior Scleritis Patients With and Without Rheumatoid Arthritis.

Authors:  Mengyao Li; Li Yang; Liangliang Zhao; Feng Bai; Xiaoli Liu
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

Review 2.  Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases.

Authors:  Miłosz Caban; Urszula Lewandowska
Journal:  Nutrients       Date:  2022-06-05       Impact factor: 6.706

3.  Case Report: Anterior Scleritis Presenting as a Primary Ocular Manifestation in Multisystem Inflammatory Syndrome in Children With COVID-19.

Authors:  Daisuke Matsubara; Daisuke Tamura; Yuka Kasuya; Yoshitaka Mizobe; Mami Hiwada; Mitsuru Seki; Shinji Makino; Takanori Yamagata
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

4.  Immunopathological Analysis of a Mouse Model of Arthritis-Associated Scleritis and Implications for Molecular Targeted Therapy for Severe Scleritis.

Authors:  Yusuke Nishio; Hiroko Taniguchi; Ayaka Takeda; Junko Hori
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

5.  Bilateral anterior and posterior scleritis in a patient with acute myelogenous leukemia.

Authors:  Pujan R Patel; Maureen C Farrell; Ani Peshtani; Meghan K Berkenstock
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-24

6.  Plasmapheresis as a viable treatment option for scleritis.

Authors:  Janine M Preble; Xihui Lin
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-16

7.  Posterior scleritis after biweekly aflibercept intravitreal injections.

Authors:  Mélanie Hébert; Eunice You; Jean-François Gravel; Ali Dirani; Serge Bourgault
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-06

Review 8.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.